It is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist)
Weight loss injections, such as GLP-1 receptor agonists like Semaglutide and Tirzepatide, have been shown to provide modest reductions in blood pressure, which may benefit individuals with hypertension
Severe abdominal pain: This could be a sign of pancreatitis
Semaglutide is generally prescribed for people who are obese or who have a high body mass index (BMI) and struggle to lose weight through diet and exercise alone
Lahey suggests sleeping with the head of your bed raised about six inches
Potential benefits may include: Improved blood sugar and A1C levels Reduced hunger and food intake Greater fullness after eating Weight reduction in some patients Once-weekly administration Results vary based on dosage, health conditions, treatment response, nutrition, physical activity, and other medications